SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: The COmmunity Cohort Study

被引：1
|
作者：
Bachelet, Vivienne C. [1 ]
Silva-Ayarza, Ignacio [1 ]
Navarrete, Maria S. [1 ]
机构：
[1] Univ Santiago de Chile, Escuela Med, Santiago, Chile
来源：
MEDWAVE | 2024年 / 23卷 / 11期
关键词：
COVID-19; Cohort studies; vaccines; SARS-CoV-2;
D O I：
10.5867/medwave.2023.11.2787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Based on the recommendations of the Vaccine Advisory Committee and the National Immunization Program, Chile implemented an early vaccination process of the population with vaccines from different laboratories. The study of neutralizing antibody levels in different population subgroups contributes to the establishment of correlates of protection against SARS-CoV-2 infection. In 2022 and 2023 we set up a community cohort of 914 adults with cardiovascular risk factors. In this cohort we are measuring the humoral immune response to exposure to SARS-CoV-2 antigens, either by vaccines or infection, as well as the incidence of COVID-19 and other adverse events. This cohort, which we call The COmmunity Cohort, is providing us with valuable information on the levels of neutralizing antibodies in these individuals and their degree of protection against COVID-19.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol
    Bachelet, Vivienne C.
    Silva-Ayarza, Ignacio
    Lizana, Francisca J.
    Gomolan, Patricio
    Silva-Villalobos, Diego
    Navarrete, Maria S.
    BMJ OPEN, 2022, 12 (05):
  • [2] Humoral Immune Response to SARS-CoV-2 in Iceland
    Gudbjartsson, Daniel F.
    Norddahl, Gudmundur L.
    Melsted, Pall
    Gunnarsdottir, Kristbjorg
    Holm, Hilma
    Eythorsson, Elias
    Arnthorsson, Asgeir O.
    Helgason, Dadi
    Bjarnadottir, Kristbjorg
    Ingvarsson, Ragnar F.
    Thorsteinsdottir, Brynja
    Kristjansdottir, Steinunn
    Birgisdottir, Kolbrun
    Kristinsdottir, Anna M.
    Sigurdsson, Martin I.
    Arnadottir, Gudny A.
    Ivarsdottir, Erna V.
    Andresdottir, Margret
    Jonsson, Frosti
    Agustsdottir, Arna B.
    Berglund, Jonas
    Eiriksdottir, Berglind
    Fridriksdottir, Run
    Gardarsdottir, Elisabet E.
    Gottfredsson, Magnus
    Gretarsdottir, Olafia S.
    Gudmundsdottir, Steinunn
    Gudmundsson, Kjartan R.
    Gunnarsdottir, Thora R.
    Gylfason, Arnaldur
    Helgason, Agnar
    Jensson, Brynjar O.
    Jonasdottir, Aslaug
    Jonsson, Hakon
    Kristjansson, Thordur
    Kristinsson, Karl G.
    Magnusdottir, Droplaug N.
    Magnusson, Olafur T.
    Olafsdottir, Lovisa B.
    Rognvaldsson, Solvi
    le Roux, Louise
    Sigmundsdottir, Gudrun
    Sigurdsson, Asgeir
    Sveinbjornsson, Gardar
    Sveinsdottir, Kristin E.
    Sveinsdottir, Maney
    Thorarensen, Emil A.
    Thorbjornsson, Bjarni
    Thordardottir, Marianna
    Saemundsdottir, Jona
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1724 - 1734
  • [3] Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
    Yang, Lu M.
    Costales, Cristina
    Ramanathan, Muthukumar
    Bulterys, Philip L.
    Murugesan, Kanagavel
    Schroers-Martin, Joseph
    Alizadeh, Ash A.
    Boyd, Scott D.
    Brown, Janice M.
    Nadeau, Kari C.
    Nadimpalli, Sruti S.
    Wang, Aileen X.
    Busque, Stephan
    Pinsky, Benjamin A.
    Banaei, Niaz
    JOURNAL OF CLINICAL VIROLOGY, 2022, 153
  • [4] Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort
    Zhao, Tianchen
    Nishi-Uchi, Takamitsu
    Omata, Fumiya
    Takita, Morihito
    Kawashima, Moe
    Nishikawa, Yoshitaka
    Yamamoto, Chika
    Kobashi, Yurie
    Kawamura, Takeshi
    Shibuya, Kenji
    Kazama, Junichiro
    Shineha, Ryuzaburo
    Tsubokura, Masaharu
    BMJ OPEN, 2022, 12 (11):
  • [5] Isotyping and quantitation of the humoral immune response to SARS-CoV-2
    Goyins, Krystal A.
    Jieh-Juen Yu
    Papp, Sara B.
    Beddard, Rachel
    Murthy, Ashlesh K.
    Chambers, James P.
    Arulanandam, Bernard P.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (12) : 1055 - 1060
  • [6] Study in dynamics of postvaccine and postexposure humoral immune response to SARS-CoV-2
    Bozhkova, Martina
    Kalchev, Yordan
    Lengerova, Gergana
    Veliyanova, Tanya
    Kalfova, Teodora
    Petrov, Steliyan
    Pasha, Danyal
    Taskov, Hristo
    Mudjeva, Marianna
    JOURNAL OF IMAB, 2021, 27 : 100 - 102
  • [7] Humoral Response to SARS-CoV-2 in Hemodialysis Patients
    Steers, Nicholas J.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (07): : 1761 - 1763
  • [8] The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients
    La Milia, Vincenzo
    Tonolo, Silvia
    Luzzaro, Francesco
    Bonato, Claudio
    Cavalli, Andrea
    Foglieni, Barbara
    Debiase, Consuelo
    Limardo, Monica
    Longhi, Selena
    Ravasi, Chiara
    Vigano, Sara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 1132 - 1134
  • [9] Humoral immune response to SARS-CoV-2 vaccination in MS patients treated with rituximab
    Torgauten, H. M.
    Cox, R. J.
    Myhr, K. -M.
    Langeland, N.
    Onyango, T. B.
    Torkildsen, O.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 775 - 775
  • [10] HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE IN RITUXIMAB-TREATED PATIENTS
    Flores-Fernandez, E.
    Vazquez-Gomez, I.
    Valera-Ribera, C.
    Andujar-Brazal, P.
    Valls-Pascual, E.
    Nogueira Coito, J. M.
    Martinez-Ferrer, A.
    Ybanez-Garcia, D.
    Alegre-Sancho, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 974 - 975
12345